Philippe Laffont
CAI

Philippe Laffont’s Caris Life Sciences CAI Stock Holding History

Philippe Laffont’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175M Hold
9,819,992
– – 0.36% 34
2026
Q1 		$176M Hold
9,819,992
– – 0.6% 31
2025
Q4 		$265M Sell
9,819,992
-322,206
-3% -$9.07M 0.66% 30
2025
Q3 		$307M Hold
10,142,198
– – 0.75% 33
2025
Q2 		$271M Buy
+10,142,198
New +$273M 0.75% 30

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Philippe Laffont's CAI Position: Q2 2026 in Review

Philippe Laffont held its Caris Life Sciences (CAI) position steady in Q2 2026 at 9,819,992 shares worth $175M. The position accounts for 0.36% of the portfolio, ranked #34.

Philippe Laffont first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $307M in Q3 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Philippe Laffont held 9,819,992 shares of Caris Life Sciences worth $175M as of Q2 2026.
  • Philippe Laffont left its Caris Life Sciences share count unchanged in Q2 2026.
  • Caris Life Sciences made up 0.36% of Philippe Laffont's portfolio in Q2 2026, its #34 holding.
  • Philippe Laffont first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Philippe Laffont's Caris Life Sciences position peaked at $307M in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Coatue Management's 13F filing for Q2 2026, filed 14 Aug 2026.